Accelerate Diagnostics Current Ratio 2010-2024 | AXDXQ
Accelerate Diagnostics current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Accelerate Diagnostics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-12-31 | $0.02B | $0.03B | 0.71 |
| 2024-09-30 | $0.03B | $0.02B | 1.50 |
| 2024-06-30 | $0.02B | $0.01B | 1.28 |
| 2024-03-31 | $0.02B | $0.02B | 1.50 |
| 2023-12-31 | $0.02B | $0.01B | 2.03 |
| 2023-09-30 | $0.03B | $0.04B | 0.86 |
| 2023-06-30 | $0.04B | $0.05B | 0.79 |
| 2023-03-31 | $0.04B | $0.07B | 0.63 |
| 2022-12-31 | $0.06B | $0.07B | 0.84 |
| 2022-09-30 | $0.07B | $0.07B | 1.00 |
| 2022-06-30 | $0.05B | $0.07B | 0.72 |
| 2022-03-31 | $0.06B | $0.11B | 0.54 |
| 2021-12-31 | $0.07B | $0.01B | 10.56 |
| 2021-09-30 | $0.07B | $0.01B | 9.52 |
| 2021-06-30 | $0.08B | $0.01B | 8.98 |
| 2021-03-31 | $0.08B | $0.01B | 11.11 |
| 2020-12-31 | $0.08B | $0.01B | 11.77 |
| 2020-09-30 | $0.09B | $0.01B | 13.02 |
| 2020-06-30 | $0.10B | $0.01B | 10.13 |
| 2020-03-31 | $0.11B | $0.01B | 16.03 |
| 2019-12-31 | $0.12B | $0.01B | 14.93 |
| 2019-09-30 | $0.13B | $0.01B | 21.93 |
| 2019-06-30 | $0.15B | $0.01B | 19.99 |
| 2019-03-31 | $0.16B | $0.01B | 25.36 |
| 2018-12-31 | $0.18B | $0.01B | 22.88 |
| 2018-09-30 | $0.19B | $0.01B | 35.26 |
| 2018-06-30 | $0.21B | $0.01B | 27.11 |
| 2018-03-31 | $0.21B | $0.01B | 27.79 |
| 2017-12-31 | $0.12B | $0.01B | 17.75 |
| 2017-09-30 | $0.13B | $0.01B | 21.23 |
| 2017-06-30 | $0.14B | $0.01B | 23.02 |
| 2017-03-31 | $0.07B | $0.01B | 13.40 |
| 2016-12-31 | $0.08B | $0.00B | 19.44 |
| 2016-09-30 | $0.09B | $0.00B | 20.61 |
| 2016-06-30 | $0.11B | $0.00B | 23.56 |
| 2016-03-31 | $0.12B | $0.01B | 24.12 |
| 2015-12-31 | $0.13B | $0.01B | 25.28 |
| 2015-09-30 | $0.04B | $0.00B | 11.47 |
| 2015-06-30 | $0.05B | $0.00B | 16.49 |
| 2015-03-31 | $0.06B | $0.00B | 17.04 |
| 2014-12-31 | $0.07B | $0.00B | 24.11 |
| 2014-09-30 | $0.07B | $0.00B | 35.24 |
| 2014-06-30 | $0.08B | $0.00B | 35.41 |
| 2014-03-31 | $0.04B | $0.00B | 23.18 |
| 2013-12-31 | $0.04B | $0.00B | 37.07 |
| 2013-09-30 | $0.05B | $0.00B | 108.36 |
| 2013-06-30 | $0.03B | $0.00B | 15.56 |
| 2013-03-31 | $0.03B | $0.00B | 26.53 |
| 2012-12-31 | $0.01B | $0.00B | 10.30 |
| 2012-10-31 | $0.01B | $0.00B | 9.71 |
| 2012-09-30 | $0.00B | 0.00 | |
| 2012-07-31 | $0.02B | $0.00B | 10.81 |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-04-30 | $0.00B | $0.00B | 4.64 |
| 2012-03-31 | $0.00B | 0.00 | |
| 2012-01-31 | $0.00B | $0.00B | 5.11 |
| 2011-10-31 | $0.00B | $0.00B | 7.00 |
| 2011-07-31 | $0.00B | $0.00B | 20.53 |
| 2011-04-30 | $0.00B | $0.00B | 6.51 |
| 2011-01-31 | $0.00B | $0.00B | 7.67 |
| 2010-10-31 | $0.00B | $0.00B | 8.21 |
| 2010-07-31 | $0.00B | $0.00B | 9.92 |
| 2010-04-30 | $0.00B | $0.00B | 1.95 |
| 2010-01-31 | $0.00B | $0.00B | 1.57 |
| 2009-10-31 | $0.00B | $0.00B | 3.50 |
| 2009-07-31 | $0.00B | $0.00B | 5.97 |
| 2009-04-30 | $0.00B | $0.00B | 4.00 |
| 2009-01-31 | $0.00B | $0.00B | 5.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $173.973B | 21.05 |
| Intuitive Surgical (ISRG) | United States | $168.513B | 69.85 |
| IDEXX Laboratories (IDXX) | United States | $52.648B | 54.79 |
| Edwards Lifesciences (EW) | United States | $45.999B | 30.49 |
| Alcon (ALC) | Switzerland | $42.296B | 28.58 |
| DexCom (DXCM) | United States | $30.925B | 46.39 |
| IQVIA Holdings (IQV) | United States | $30.576B | 17.28 |
| Mettler-Toledo (MTD) | United States | $25.872B | 30.71 |
| STERIS (STE) | Ireland | $23.889B | 25.46 |
| Waters (WAT) | United States | $16.738B | 22.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.603B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.379B | 68.52 |
| Sysmex ADR (SSMXY) | Japan | $8.712B | 27.68 |
| Globus Medical (GMED) | United States | $7.940B | 18.27 |
| Masimo (MASI) | United States | $7.862B | 26.46 |
| Teleflex (TFX) | United States | $5.233B | 8.45 |
| Glaukos (GKOS) | United States | $4.855B | 0.00 |
| TransMedics (TMDX) | United States | $3.903B | 59.33 |
| Integer Holdings (ITGR) | United States | $3.729B | 18.61 |
| LivaNova (LIVN) | United Kingdom | $2.667B | 15.26 |
| Alphatec Holdings (ATEC) | United States | $2.215B | 0.00 |
| Veracyte (VCYT) | United States | $2.153B | 29.75 |
| PROCEPT BioRobotics (PRCT) | United States | $2.137B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.981B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.881B | 16.91 |
| Artivion (AORT) | United States | $1.749B | 97.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.010B | 5.79 |
| OPKO Health (OPK) | United States | $0.992B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.17 |
| Tandem Diabetes Care (TNDM) | United States | $0.759B | 0.00 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.641B | 0.00 |
| AxoGen (AXGN) | United States | $0.640B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 4.30 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.502B | 8.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.474B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.387B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.354B | 8.99 |
| Delcath Systems (DCTH) | United States | $0.350B | 83.42 |
| AngioDynamics (ANGO) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| RxSight (RXST) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.288B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.274B | 18.89 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| 908 Devices (MASS) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.193B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.112B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.73 |